Foamix Pharmaceuticals Ltd (FOMX)

[realfast95]

Foamix Pharmaceuticals to Present at the Cowen and Company’s 40th Annual Health Care Conference
February 25, 2020 at 8:00 AM EST
PDF Version

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, announced today that David Domzalski, Chief Executive Officer, will provide a corporate update at the Cowen 40th Annual Health Care Conference, taking place March 2-4, 2020 in Boston, Massachusetts.